Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C

<div>Serum hepcidin-25 levels were measured by LC-MS/MS. Median serum hepcidin-25 levels of control participants and CHC patients were 23.3 ng/mL (range, 3.9-47.3) and 7.2 ng/mL (range, 0-27.3). Serum hepcidin-25 levels in patients with CHC were significantly lower than in the control group (<i>P</i> = 0.0002; Wilcoxon-Mann-Whitney U test). Bottom and top edges of the boxes are the 25th and 75th percentiles, respectively. Median values are shown by a line within the box.</div>

Canadian Journal of Gastroenterology and Hepatology

fig2

Figure 2

Figure 2: Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C 

Figure 2 | Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C 